Fundraising Fox
Tres alchemix AI創薬プラットフォーム研究開発
4 employees on LinkedIn · 1 known investors
Find your way into Tres alchemix AI創薬プラットフォーム研究開発
Sign up to see every warm intro you have to Tres alchemix AI創薬プラットフォーム研究開発
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tres alchemix AI創薬プラットフォーム研究開発 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tres Alchemix develops AI platforms that combine quantum-level chemical calculations with multi-omics models trained on curated biochemical and pharmacological data to predict how chemicals behave in the human body, including drug properties, chemical-protein interactions, and pharmacokinetics/pharmacodynamics. The company applies these technologies to AI-driven drug development and biological research questions.
Investors · 1
Frequently asked questions
- What does Tres alchemix AI創薬プラットフォーム研究開発 do?
- Tres Alchemix develops AI platforms that combine quantum-level chemical calculations with multi-omics models trained on curated biochemical and pharmacological data to predict how chemicals behave in the human body, including drug properties, chemical-protein interactions, and pharmacokinetics/pharmacodynamics. The company applies these technologies to AI-driven drug development and biological research questions.
- Who are Tres alchemix AI創薬プラットフォーム研究開発's investors?
- Tres alchemix AI創薬プラットフォーム研究開発's investors include Dnx Ventures.